指南与共识类风湿关节炎

类风湿关节炎疾病活动的患者报告结局指标:遵循COSMIN指南的系统综述

Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review following COSMIN guidelines.
指南 / 共识 · RMD Open · 2022-01-01

本系统综述遵循COSMIN指南评估所有用于类风湿关节炎疾病活动的患者报告结局指标(PROMs),检索至2019年1月,共纳入10项PROMs。因缺乏内容效度证据,无PROM可被推荐用于使用类别A。

要点

  • 共识别10项用于类风湿关节炎疾病活动的PROMs。
  • 因缺乏内容效度证据,无PROM可被推荐为使用类别A。
  • 所有纳入PROMs均在COSMIN指南发表前开发。

核心结论

  • 缺乏内容效度证据限制了合适PROM的选择,因此无PROM可被推荐使用。

研究设计与样本

  • 系统综述,注册号PROSPERO CRD42020176176,检索策略基于既往类似系统综述并扩展至2019年1月,由两名独立评估者按COSMIN指南对纳入文献进行评分。

主要发现

  • 共识别668篇摘要,纳入10篇文章,另从既往综述中识别21篇,共识别10项PROMs。
  • 因缺乏内容效度证据,无PROM可被纳入推荐使用类别A。

关键数值与推荐

  • COSMIN指南要求内容效度证据,因缺乏该证据,无PROM达到推荐使用类别A。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 所有纳入的PROMs均在COSMIN指南发表前开发。
  • 未来针对类风湿关节炎疾病活动的PROMs研究必须提供内容效度证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The current standard of care in rheumatoid arthritis (RA) requires regular assessment of disease activity (DA). All standard RA DA measurement instruments require joint counts to be undertaken by a healthcare professional with/without a blood test. Few healthcare providers have the capacity to assess patients as frequently as stipulated by guidelines. Patient Reported Outcome Measures (PROMs) could be an efficient and informative way to assess RA DA, which is highlighted by the SARS-COV-2 pandemic, as most consultations are remote rather than face-to-face. We aimed to assess all PROMs for RA DA against the internationally recognised COSMIN guidelines to provide evidence-based recommendations to select the most suitable PROMs. METHODS: Review registered on PROSPERO as CRD42020176176. The search strategy was based on a previous similar systematic review and expanded to include all articles up to January 2019. All identified articles were rated by two independent assessors following the COSMIN guidelines. RESULTS: 668 abstracts were identified, with 10 articles included. A further 21 were identified from a previous review. Ten PROMs were identified. There was insufficient evidence to place any of the identified PROMs into recommendation for use category A due to lack of evidence for content validity, as stipulated by the COSMIN guidelines. CONCLUSION: Lack of evidence of content validity limits suitable PROM selection, therefore none can be recommended for use. It is acknowledged that all included PROMs were developed before the COSMIN guidelines were published. Future research on PROMs for RA DA must provide evidence of content validity.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Pickles T, Macefield R, Aiyegbusi OL, et al. Patient Reported Outcome Measures for Rheumatoid Arthritis Disease Activity: a systematic review following COSMIN guidelines. RMD Open. 2022. PMID: 35351807. doi:10.1136/rmdopen-2021-002093

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。